Breakthrough Drug Vetmedin Gives Canines Afflicted with Heart Disease 2X Longer Lifespan
One of my biggest fears since acquiring my beloved Cavalier King Charles Spaniel is the prevelance of heart disease within the breed, with most Cavaliers suffering from Mitral Valve Disease by age 4. Statistics have shown that heart disease affects 25% of all dogs over age 7. In the UK, where the new drug Vetmedin has been going through trials, nearly two million dogs are affected by heart disease.
The QUEST study on Vetmedin has been published in the September/October 2008 Journal of Veterinary Internal Medicine. This has been the largest study of its kind in veterinary cardiology, tracking 260 dogs in 11 countries, on three continents, for a period of three years.
Compared with conventional heart disease treatments, Vetmedin has been proven to extend the lifespan of afflicted dogs by double the time currently possible, changing the way veterinary cardiologists will treat canine heart disease.
Vetmedin is indicated for the most common form of heart failure that most regularly afflicts small breeds such as Cavalier King Charles Spaniels, Poodles, Chihuahuas and Dachshunds. Pet owners should feel encouraged by this development, as veterinarians are learning more about canine cardiology and how to treat it.
According to Vetmedin’s website, the only reported side effect is occasional vomiting. Here is hoping this breakthrough drug will help many dogs live longer and more fulfilling lives!